Biopharma Due Diligence

A global biopharma company was evaluating an acquisition whose potential indications ranged from gastrointestinal disorders to ophthalmology. With a key leader out on vacation and the deadline for a non-binding term sheet drawing near, the company’s head of Commercial Business Development turned to Business Talent Group.

In the span of a few days, we delivered a two-person team to help the company extend and finalize its commercial evaluation. A biotech investment specialist customized a model that looked at multiple scenarios and helped size patient populations across different indications. An analyst assessed market access and competitive dynamics. A week later, the team had the figures it needed to make a successful bid; they are now proceeding to the next phase of the acquisition.

We take our clients' confidentiality seriously. We've changed their names, but the results are real. For further details, email us at or complete the Learn More form on this page.